<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Defects in T-cell function in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> might influence their capacity to mount efficient antitumor immune responses </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we identified highly reduced IL-4-, IL-10-, and IL-21-induced phosphorylation of STAT6 and STAT3 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating T cells (TILs) in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, contrasting other non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> TILs </plain></SENT>
<SENT sid="2" pm="."><plain>By combining phospho-protein-specific flow cytometry with several T-cell markers, we identified that CD4(+)CD45RO(+)CD62L(-) FL TILs were largely nonresponsive to cytokines, in contrast to the corresponding autologous peripheral blood subset </plain></SENT>
<SENT sid="3" pm="."><plain>We observed differential expression of the inhibitory receptor <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 in FL TILs and peripheral blood T cells </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, CD4(+)<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1(hi) FL TILs, containing T(FH) and non-T(FH) cells, had lost their cytokine responsiveness, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 TILs had <z:mpath ids='MPATH_458'>normal</z:mpath> cytokine signaling </plain></SENT>
<SENT sid="5" pm="."><plain>However, this phenomenon was not <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> specific, because tonsil T cells were similar to FL TILs </plain></SENT>
<SENT sid="6" pm="."><plain>FL <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells were negative for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 ligands, but <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-L1(+) histiocytes were found within the T cell-rich zone of the neoplastic follicles </plain></SENT>
<SENT sid="7" pm="."><plain>Disruption of the microenvironment and in vitro culture of FL TILs could restore cytokine signaling in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1(hi) subset </plain></SENT>
<SENT sid="8" pm="."><plain>Because FL TILs in vivo probably receive suppressive signals through <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1, this provides a rationale for testing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 Ab in combination with immunotherapy in patients with FL </plain></SENT>
</text></document>